Search | Webyourself Social Media Platform

Vamshee Sing added article Health
2023-03-01 11:37:16 -

Dengue Vaccine Market Size (2022-2028) Industry Trends
The global dengue vaccine market size was valued at USD 361 million in 2021 and is poised to grow at a significant CAGR of 17.2% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Dengue Vaccine market by Product Type (CYD-TDV (Dengvaxia),...

0 Comments 0 Shares 1567 Views 0 Reviews

Please log in to like, share and comment!
Sanjay Mishra added article Other
2024-11-04 04:36:37 -

Dengue Vaccine Market Size, Share, Key Drivers, Trends, Challenges and Competitive Analysis
"Global Dengue Vaccine Market – Industry Trends and Forecast to 2031 Global Dengue Vaccine Market, By Type (Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine), Treatment (Diuretic, Anti-Allergic, Blood Thinners, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare,...

0 Comments 0 Shares 79 Views 0 Reviews

Please log in to like, share and comment!
Sanjay Mishra added article Health
2024-11-11 06:33:24 -

Dengue Vaccine Market Size, Share, Trends, Growth and Competitive Analysis
"Global Dengue Vaccine Market – Industry Trends and Forecast to 2031 Global Dengue Vaccine Market, By Type (Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine), Treatment (Diuretic, Anti-Allergic, Blood Thinners, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare,...

0 Comments 0 Shares 62 Views 0 Reviews

Please log in to like, share and comment!
Vamshee Sing added article Health
2024-02-05 11:52:55 -

Dengue Vaccine Market Size, Dynamics, Regional Analysis 2024
The report "Dengue Vaccine Market by Product Type (CYD-TDV (Dengvaxia), DENVax, TetraVax-DV, Others), by Vaccine Type (Live Attenuated Vaccine, Killed Vaccine, Others), By End User (Hospitals, Clinics, Government Institutes, Non-Governmental Organizations (NGOs)) - Global Forecasts to 2030", is projected to reach USD 472.6 million in 2023, registering at a Compound Annual Growth Rate...

0 Comments 0 Shares 1169 Views 0 Reviews

Please log in to like, share and comment!